Search Results - "Cagney, N."

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors by Pike, Luke R.G., Bang, Andrew, Mahal, Brandon A., Taylor, Allison, Krishnan, Monica, Spektor, Alexander, Cagney, Daniel N., Aizer, Ayal A., Alexander, Brian M., Rahma, Osama, Balboni, Tracy, Ott, Patrick A., Hodi, F. Stephen, Schoenfeld, Jonathan D.

“…Therapeutic radiation has conflicting immune effects: radiation therapy (RT)-induced immunogenic cell death can contribute to immune response, but lymphocytes…”
Get full text

Wake modes of a cylinder undergoing free streamwise vortex-induced vibrations by Cagney, N., Balabani, S.

“…Simultaneous measurements of the response of a circular cylinder experiencing vortex-induced vibrations (VIVs) in the streamwise direction and the resulting…”
Get full text

Fluid forces acting on a cylinder undergoing streamwise vortex-induced vibrations by Cagney, N., Balabani, S.

“…This brief communication examines the fluid forces acting on a cylinder free to move in the streamwise direction throughout its response regime. The amplitude…”
Get full text

Mode competition in streamwise-only vortex induced vibrations by Cagney, N., Balabani, S.

“…Time-resolved Particle-Image Velocimetry (PIV) has been used to study mode competition and transient behaviour in the wake of a cylinder experiencing…”
Get full text

Effects of cell motility and morphology on the rheology of algae suspensions by Cagney, N., Zhang, T., Bransgrove, R., Allen, M. J., Balabani, S.

“…Algae have been proposed as a source of biofuels and high value chemical products, but if this potential is to be fully realised, it is crucial to understand…”
Get full text

Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge by N. Cagney, Daniel, Alexander, Brian M., Hodi, F. Stephen, Buchbinder, Elizabeth I., Ott, Patrick A., Aizer, Ayal A.

“…Novel systemic therapies with anti-tumor activity in the brain including small molecules targeting BRAF and MEK, and immune checkpoint inhibition, offer the…”
Get full text

Magnetic Resonance–Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort by Leeman, Jonathan E., Cagney, Daniel N., Mak, Raymond H., Huynh, Mai Anh, Tanguturi, Shyam K., Singer, Lisa, Catalano, Paul, Martin, Neil E., D'Amico, Anthony V., Mouw, Kent W., Nguyen, Paul L., King, Martin T., Han, Zhaohui, Williams, Christopher, Huynh, Elizabeth

“…Stereotactic magnetic resonance (MR)–guided adaptive radiation therapy (SMART) for prostate cancer allows for MR-based contouring, real-time MR motion…”
Get full text

Constraining the source of mantle plumes by Cagney, N., Crameri, F., Newsome, W.H., Lithgow-Bertelloni, C., Cotel, A., Hart, S.R., Whitehead, J.A.

“…In order to link the geochemical signature of hot spot basalts to Earth's deep interior, it is first necessary to understand how plumes sample different…”
Get full text

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy by Cagney, Daniel N, Dunne, Mary, O'Shea, Carmel, Finn, Marie, Noone, Emma, Sheehan, Martina, McDonagh, Lesley, O'Sullivan, Lydia, Thirion, Pierre, Armstrong, John

“…Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation…”
Get full text

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study by Cagney, Daniel N, Martin, Allison M, Catalano, Paul J, Redig, Amanda J, Lin, Nancy U, Lee, Eudocia Q, Wen, Patrick Y, Dunn, Ian F, Bi, Wenya Linda, Weiss, Stephanie E, Haas-Kogan, Daphne A, Alexander, Brian M, Aizer, Ayal A

“…Brain metastases are associated with significant morbidity and mortality. Population-level data describing the incidence and prognosis of patients with brain…”
Get full text

Update on Radiation Therapy for Central Nervous System Tumors by Rahman, Rifaquat, Sulman, Erik, Haas-Kogan, Daphne, Cagney, Daniel N.

“…Radiation therapy has long been a critical modality of treatment of patients with central nervous system tumors, including primary brain tumors, brain…”
Get full text

The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology by Cagney, Daniel N, Sul, Joohee, Huang, Raymond Y, Ligon, Keith L, Wen, Patrick Y, Alexander, Brian M

“…In early 2016, the FDA and the National Institutes of Health (NIH) published the first version of the glossary included in the Biomarkers, EndpointS, and other…”
Get full text

Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy by Bang, Andrew, Wilhite, Tyler J., Pike, Luke R.G., Cagney, Daniel N., Aizer, Ayal A., Taylor, Allison, Spektor, Alexander, Krishnan, Monica, Ott, Patrick A., Balboni, Tracy A., Hodi, F. Stephen, Schoenfeld, Jonathan D.

“…To analyze immune-related adverse events (ir-AEs) in patients treated with radiation and immune checkpoint blockade. We retrospectively reviewed records from…”
Get full text

MRI in Radiation Oncology After the COVID-19 Pandemic by Singer, Lisa, Marques, Alex, Cagney, Daniel N., Kaza, Evangelia

Get full text

Seizures Among Patients With Brain Metastases: A Population- and Institutional-Level Analysis by Lamba, Nayan, Catalano, Paul J., Cagney, Daniel N., Haas-Kogan, Daphne A., Bubrick, Ellen J., Wen, Patrick Y., Aizer, Ayal A.

“…To test the hypothesis that subets of patients with brain metastases (BrM) without seizures at intracranial presentation are at increased risk for developing…”
Get full text

Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study by Martin, Allison M, Cagney, Daniel N, Catalano, Paul J, Warren, Laura E, Bellon, Jennifer R, Punglia, Rinaa S, Claus, Elizabeth B, Lee, Eudocia Q, Wen, Patrick Y, Haas-Kogan, Daphne A, Alexander, Brian M, Lin, Nancy U, Aizer, Ayal A

“…Population-based estimates of the incidence and prognosis of brain metastases at diagnosis of breast cancer are lacking. To characterize the incidence…”
Get more information

Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma by Youssef, Gilbert, Rahman, Rifaquat, Bay, Camden, Wang, Wei, Lim-Fat, Mary Jane, Arnaout, Omar, Bi, Wenya Linda, Cagney, Daniel N, Chang, Yuh-Shin, Cloughesy, Timothy F, DeSalvo, Matthew, Ellingson, Benjamin M, Flood, Thomas F, Gerstner, Elizabeth R, Gonzalez Castro, L Nicolas, Guenette, Jeffrey P, Kim, Albert E, Lee, Eudocia Q, McFaline-Figueroa, Jose R, Potter, Christopher A, Reardon, David A, Huang, Raymond Y, Wen, Patrick Y

“…The Response Assessment in Neuro-Oncology (RANO) criteria are widely used in high-grade glioma clinical trials. We compared the RANO criteria with updated…”
Get full text

Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices by Bitterman, Danielle S, Cagney, Daniel N, Singer, Lisa L, Nguyen, Paul L, Catalano, Paul J, Mak, Raymond H

“…Abstract Historically, the gold standard for evaluation of cancer therapeutics, including medical devices, has been the randomized clinical trial. Although…”
Get full text

Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non–small cell lung cancer and melanoma brain metastases by Qian, Jack M., Martin, Allison M., Martin, Kate, Hammoudeh, Lubna, Catalano, Paul J., Hodi, F. Stephen, Cagney, Daniel N., Haas‐Kogan, Daphne A., Schoenfeld, Jonathan D., Aizer, Ayal A.

“…Background Prior literature has suggested synergy between immune checkpoint therapy (ICT) and radiotherapy (RT) for the treatment of brain metastases (BrM),…”
Get full text

Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART) by Lee, Grace, Han, Zhaohui, Huynh, Elizabeth, Tjong, Michael C, Cagney, Daniel N., Huynh, Mai Anh, Kann, Benjamin H., Kozono, David, Leeman, Jonathan E., Singer, Lisa, Williams, Christopher L., Mak, Raymond H.

“…•26 central (19 ultra-central) oligo-metastases were treated by isotoxic 5-fraction SMART•Adaptive replanning was indicated in 96% to meet OAR metrics and/or…”
Get full text